Art

J-GLOBAL ID：201902206790137198   Reference number：19S0480453

CD30 ligand is a new therapeutic target for central nervous system autoimmunity

Author (9)： Shinoda, Koji (Division of Host Defense, Medical Institute of Bioregulation, Kyushu University) ,  Shinoda, Koji (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) ,  Oyamada, Akiko (Division of Host Defense, Medical Institute of Bioregulation, Kyushu University) ,  Yamada, Hisakata (Division of Host Defense, Medical Institute of Bioregulation, Kyushu University) ,  Yoshikai, Yasunobu (Division of Host Defense, Medical Institute of Bioregulation, Kyushu University) ,  Kira, Jun-ichi (Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University) ,  Sun, Xun (Department of Immunology, China Medical University) ,  Muta, Hiromi (Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University) ,  Podack, Eckhard R. (Department of Microbiology and Immunology, University of Miami)
Material： Journal of Autoimmunity
Volume： 57  Page： 14-23  Publication year： 2015 
JST Material Number： SCOPUS  ISSN： 0896-8411  CODEN： JOAUE 
Country of issue： United Kingdom (GBR)  Language： English (EN)

Terms in the title (2)： CD30 ,  IS